Solid Biosciences has surged back into the Duchenne muscular dystrophy (DMD) gene therapy race. | Solid Biosciences has ...
The company raised $200 million after early findings hinted its therapy could be more potent than others like it, including ...
Explore the new material that transforms from solid to liquid on demand, revolutionizing technology in various fields.
The race for the “holy grail” of EV batteries is heating up. Mercedes-Benz is now testing EVs with solid-state ...
Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company” or “Solid”), a life sciences company developing precision genetic ...
Solid Biosciences (SLDB) stock surges after strong Phase 1/2 data for its Duchenne therapy SGT-003. Read more here.
As Rugare Gomo, a business and leadership coach, as well as the author of “Dreams: Forging My Own Path” explains, embracing ...